A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 1,392 shares of BAX stock, worth $25,710. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,392
Previous 1,392 -0.0%
Holding current value
$25,710
Previous $42.4 Million 24.66%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

SELL
$27.8 - $34.02 $30,357 - $37,149
-1,092 Reduced 43.96%
1,392 $42.4 Million
Q4 2023

Feb 14, 2024

BUY
$31.71 - $38.95 $78,767 - $96,751
2,484 New
2,484 $96.9 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $9.31B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Foster Dykema Cabot & Partners, LLC Portfolio

Follow Foster Dykema Cabot & Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Dykema Cabot & Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foster Dykema Cabot & Partners, LLC with notifications on news.